Rhinitis, Allergic: Clinical Trials

21 trials for Rhinitis, Allergic, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

21 unknown. 21 Phase 3, 4 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 321Unknown 21
Phase 24Unknown 4

Follow Rhinitis, Allergic: new trials by email Literature Review of Rhinitis, Allergic trials Research Report on Rhinitis, Allergic

Trials (filtered) newest first · largest first

All 21 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy/ Safety of Product CM9241GRU in Patients With Perennial Allergic Rhinitis
Product CM9241GRU, Placebo - Rhinitis, Allergic, Perennial
Phase 3UnknownAche Laboratorios Farmaceuticos S.A.4322024-09-012024-08-29
Efficacy and Safety of MAZ-101 in the Treatment of Persistent Allergic Rhinitis (PER)
MAZ-101association, DYMISTA® - Allergic Rhinitis
Phase 3UnknownEMS5142024-09-012024-02-16
Efficacy and Safety Evaluation for the Treatment of HDM Induced Allergic Asthma and Rhinitis/Rhinoconjunctivitis
MM09 allergoid-mannan conjugates subcutaneous (3.000 UTm/mL), MM09 allergoid-mannan conjugates Sublingual (3.000 UTm/mL), MM09 allergoid-mannan conjugates Sublingual (9.000 UTm/mL) - House Dust Mite Allergy, Perennial Allergic Rhinitis
Phase 3UnknownInmunotek S.L.4002022-12-012022-11-18
Observation on the Efficacy and Mechanism of SLIT With Dust Mite Allergen for PAR
Dust mite drops (trade name: Changdi, Zhejiang Tawu Biotechnology Co. Ltd.). - Allergic Rhinitis
Phase 2 / Phase 3UnknownPeople's Hospital of Anshun City of Guizhou Province602022-12-012022-10-06
Efficacy and Safety Assessment of Beltavac® With Polymerized Extract of HDM
House dust mites allergoid from Dermatophagoides pteronyssinus and Dermatophagoides farinae, Placebo - House Dust Mite Allergy
Phase 3UnknownProbelte Pharma S.L.U.3502022-01-172024-07-18
Effect of Sublingual Immunotherapy on Platlet factor4 Level in Children
sublingual immunotherapy - Allergic Rhinitis
Phase 3UnknownZagazig University302021-04-122021-04-21
Clinical Efficacy and Safety of Subcutaneous Immunotherapy With gpASIT+™ in Patients With Grass Pollen-induced Allergic Rhinoconjunctivitis
Placebo solution, gpASIT+TM - Hay Fever
Phase 3UnknownASIT Biotech S.A.6242019-01-022018-10-30
Traditional Chinese Medicine on Gut Microbiota and Allergic Diseases
Bu-Zhong-Yi-Qi-Tang, placebo - Allergic Rhinitis
Phase 3UnknownChang Gung Memorial Hospital602018-01-102018-01-26
Efficacy and Safety of So-Cheong-Ryong-Tang on Perennial Allergic Rhinitis
SCRT, Placebos - Perennial Allergic Rhinitis
Phase 3UnknownKyung Hee University Hospital at Gangdong1542016-12-312017-03-14
Effectiveness of Bifidobacteria in Children Affected by Seasonal Allergic Rhinitis
Bifidobacteria, placebo - Seasonal Allergic Rhinitis
Phase 3UnknownUniversity of Campania Luigi Vanvitelli402016-12-012018-06-26
Efficacy and Safety of Sublingual Immunotherapy (SLIT)
sublingual immunotherapy with allergen extract, sublingual immunotherapy with placebo - Allergic Rhinitis
Phase 3UnknownRoxall Medizin1202016-11-012015-11-03
A Multicenter Study to Evaluate Safety and Efficacy of Specific Immunotherapy With Modified Allergen Extracts
modified allergen extract, Placebo - Allergic Rhinitis, Allergic Conjunctivitis
Phase 3UnknownRoxall Medizin1502016-10-012015-11-03
Safety and Efficacy Study With Allergen Extracts of House Dust Mites for Specific Sublingual Immunotherapy
Allergen extract, Placebo - Allergic Rhinitis
Phase 3UnknownRoxall Medizin1302016-09-012015-11-03
Evaluation of Efficacy and Safety of Specific Immunotherapy With Modified Allergen Extracts of House Dust Mites
modified allergen extract of house dust mites, placebo - Allergic Rhinitis
Phase 3UnknownRoxall Medizin1202016-04-012015-11-03
Allergic Rhinitis, Immunotherapy and Vitamin d
Vitamin D3, placebo - Allergy
Phase 2 / Phase 3UnknownHospital General de Mexico602016-03-012016-04-14
Clinical Equivalence of Azelastine Hydrochloride and Fluticasone Propionate, 137/50 mcg Nasal Spray to Dymista™
Azelastine hydrochloride and Fluticasone propionate, Dymista™, Placebo - Seasonal Allergic Rhinitis
Phase 3UnknownTeva Pharmaceuticals USA15352014-08-012014-09-25
The Efficacy and Safety of Sanfujiu on Patients With Persistent Allergic Rhinitis: Randomized Controlled Study
Sanfujiu, Placebo - Allergic Rhinitis
Phase 3UnknownGuangdong Provincial Hospital of Traditional Chinese Medicine4532014-07-012017-07-21
Comparison of Desloratadine Associated With Prednisolone (Tablet)Versus Dexchlorpheniramine Associated With Betamethasone (Tablet) for Adult Persistent Allergic Rhinitis Treatment
Desloratadine + Prednisolone, Dexchlorpheniramine + Betamethasone - Allergic Rhinitis
Phase 3UnknownEMS2342013-10-012013-09-25
EWO1 in Persistent Allergic Rhinitis Patients
EWO1 - Rhinitis, Allergic, Perennial
Phase 2 / Phase 3UnknownChina Medical University Hospital602004-11-012007-07-25
Use of Probiotic Bacteria in Prevention of Allergic Disease in Children 1999-2008
Mixture of probiotic bacteria and prebiotic oligosaccharide - Atopic Dermatitis, Food Hypersensitivity
Phase 2 / Phase 3UnknownUniversity of Helsinki1999-10-012006-10-18

Showing 20 of 21. Sign in to see all of them.

Narrower conditions

Rhinitis, Allergic, Perennial (5)  ·  Rhinitis, Allergic, Seasonal (4)  ·  Conjunctivitis, Allergic (2)  ·  Dust Mite Allergy (2)  ·  Hypersensitivity (2)  ·  Asthma (1)  ·  Dermatitis, Atopic (1)  ·  Food Hypersensitivity (1)

Broader conditions

Hypersensitivity, Immediate (21)  ·  Immune System Diseases (21)  ·  Nose Diseases (21)  ·  Otorhinolaryngologic Diseases (21)  ·  Respiratory Hypersensitivity (21)  ·  Respiratory Tract Diseases (21)  ·  Rhinitis (21)  ·  Hypersensitivity (19)  ·  Conjunctival Diseases (2)  ·  Conjunctivitis (2)  ·  Eye Diseases (2)  ·  Bronchial Diseases (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Dermatitis (1)

Interventions

Allergens (2)  ·  Sublingual Immunotherapy (2)  ·  dexchlorpheniramine (2)  ·  Antigens, Dermatophagoides (1)  ·  Betamethasone (1)  ·  Cholecalciferol (1)  ·  Fluticasone (1)  ·  Guaifenesin (1)  ·  Prednisolone (1)  ·  Pseudoephedrine (1)  ·  Vitamin D (1)  ·  azelastine (1)  ·  bu-zhong-yi-qi-tang (1)  ·  desloratadine (1)

Sponsors

Roxall Medizin (4)  ·  EMS (2)  ·  ASIT Biotech S.A. (1)  ·  Ache Laboratorios Farmaceuticos S.A. (1)  ·  Chang Gung Memorial Hospital (1)  ·  China Medical University Hospital (1)  ·  Guangdong Provincial Hospital of Traditional Chinese Medicine (1)  ·  Hospital General de Mexico (1)  ·  Inmunotek S.L. (1)  ·  Kyung Hee University Hospital at Gangdong (1)  ·  Mantecorp Industria Quimica e Farmaceutica Ltd. (1)  ·  People's Hospital of Anshun City of Guizhou Province (1)  ·  Probelte Pharma S.L.U. (1)  ·  Teva Pharmaceuticals USA (1)  ·  University of Campania Luigi Vanvitelli (1)

Countries

Spain (4)  ·  China (2)  ·  Germany (2)  ·  Taiwan (2)  ·  Brazil (1)  ·  Finland (1)  ·  Italy (1)  ·  Mexico (1)  ·  South Korea (1)  ·  United States (1)

Top investigators

Ana Isabel Tabar Purroy, MD. PhD (1)  ·  Bachert Claus, Prof Dr (1)  ·  Chuanjian Lu, Doctor (1)  ·  Darin Brimhall, DO, FACP (1)  ·  Erkki Savilahti, Professor (1)  ·  Fangming Chen, MB (1)  ·  Guangjun Tang, MD (1)  ·  Long Chai, MM (1)  ·  Min-Chien Yu, Ph.D. (1)  ·  Minhee Kim (1)  ·  Mohammad Romeh (1)  ·  Sien-hung Yang, Ph.D. (1)

Results publications

PMID 12668793, PMID 14674933, PMID 15313870, PMID 15461603, PMID 15516669, PMID 15750716, PMID 15898976, PMID 16930249, PMID 18331513, PMID 18595980, PMID 19925886, PMID 19968632, PMID 20545698, PMID 20816182, PMID 21122901, PMID 21771118, PMID 21783242, PMID 22093109, PMID 22224763, PMID 22361496, PMID 22627366, PMID 23348417, PMID 23791985, PMID 24631153, PMID 24679069, PMID 25171868, PMID 25644617, PMID 26141263, PMID 26300945, PMID 26874355, PMID 26922931, PMID 26932169, PMID 26949057, PMID 27329923, PMID 28270216, PMID 28602936, PMID 28785597, PMID 28917723, PMID 28963290, PMID 29214012, PMID 29771013, PMID 29774680, PMID 30142344, PMID 30233198, PMID 30263032, PMID 30326954, PMID 30472801, PMID 33273461, PMID 34857814, PMID 37438187

NIH funding

2017 (1)